SCHEMBL2818845

SCHEMBL2818845

CCOC(=O)Cc1nc(-c2ccc(F)cc2)oc1-c1ccc(Cl)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.45
GAA P10253 1/20 0.44
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TARBP2 Q15633 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PPARG P37231 4/20 0.39
PPARA Q07869 4/20 0.39
NPSR1 Q6W5P4 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HPGD P15428 1/20 0.38
PPARD Q03181 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13115652 0.92 HSD17B10 (0.54) HSD17B10GAAALDH1A1TP53TRPM8
SCHEMBL13115656 0.89 SMN1; SMN2 (0.50) HSD17B10USP2ALDH1A1TP53TRPM8
SCHEMBL13116221 0.89 TARBP2 (0.48) HSD17B10GAAALDH1A1TP53MEN1
SCHEMBL13115699 0.89 HSD17B10 (0.44) HSD17B10GAAALDH1A1MEN1KMT2A
SCHEMBL13115697 0.88 HSD17B10 (0.46) HSD17B10ALDH1A1TP53MEN1KMT2A
SCHEMBL13116031 0.88 HSD17B10 (0.44) HSD17B10GAAALDH1A1MEN1KMT2A
SCHEMBL2819713 0.88 GAA (0.44) HSD17B10GAAUSP2ALDH1A1TP53
SCHEMBL13115981 0.87 HSD17B10 (0.43) HSD17B10GAAUSP2ALDH1A1TP53
SCHEMBL13116080 0.87 HSD17B10 (0.45) HSD17B10GAAUSP2ALDH1A1TP53
SCHEMBL13115980 0.87 GAA (0.43) HSD17B10GAAUSP2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed
US-20040127527-A1 Large conductance calcium-activated k channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER KCNN3, KCNN2, KCNN1 HSD17B10 3872/4885GAA 4627/4885USP2 3553/4885
US-20040127527-A1 Large conductance calcium-activated k channel opener KCNN1, KCNN4, KCNN3 HSD17B10 3457/4885GAA 4695/4885USP2 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.